Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-24 @ 9:23 PM
NCT ID:
NCT02305732
Eligibility Criteria:
Inclusion Criteria:
* Patients with a serious disease expected to require or requiring a transfusion of platelet component(s)
* Patient population as defined by each Investigator and their institutional review board (IRB).
* Patient provides written informed consent
Exclusion Criteria
* Documented allergy to psoralens
* Neonatal patients treated with phototherapy devices that emit wavelengths less than 425 nm due to the potential for erythema resulting from interaction between ultraviolet light and amotosalen.
* Pregnant women in their third trimester of pregnancy (due to possibility the neonate may need bilirubin light treatment after birth).
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02305732
Study Brief:
Protocol Section:
NCT02305732